LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (2291.HK)
HKSE · HKD · Healthcare · Medical Devices
HK$14.99 (+8.07%) as of
Key statistics
- Market cap
- 5.10B
- P/E (TTM)
- 22.71
- Forward P/E
- 7.90
- EPS (TTM)
- 0.660
- Dividend yield
- 4.13%
- 52-week range
- 8.330 – 19.800
- Beta
- -0.14
- Revenue (TTM)
- 508.38M
- Profit margin
- 40.18%
- Analyst target
- HK$29.80
- Volume
- 1.20M
About LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the manufacture and sale of interventional treatment series occluders and heart valve medical devices. It operates through Occluder Business and Heart Valve Business segments. The company also researches, develops, manufacture, and sale interventional treatment series occluders for defective congenital heart disease; and manufacture and sale heart valve medical devices. Its products include atrial septal defect, ventricular septal defect, patent ductus arteriosus, patent foramen ovale, left atrial appendage, and aortic and peripheral occluders, as well as aortic and mitral valve occluder products; atrial septal puncture and procedural accessories; interatrial shunt device; mechanical circulatory support products; and hypertensive device treatment products. In addition, it is involved in manufacturing industry; technology development; and trading activities. The company serves its products through distributors and direct sales. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. operates as a subsidiary of Lepu Medical Technology (Beijing) Co., Ltd.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Shanghai, China
- Employees
- 371
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.